1iw4: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older edit
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,327,066 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,327,066 edits
No edit summary
 
(12 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:1iw4.jpg|left|200px]]
<!--
The line below this paragraph, containing "STRUCTURE_1iw4", creates the "Structure Box" on the page.
You may change the PDB parameter (which sets the PDB file loaded into the applet)
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
or leave the SCENE parameter empty for the default display.
-->
{{STRUCTURE_1iw4|  PDB=1iw4  |  SCENE=  }}
'''Solution structure of ascidian trypsin inhibitor'''


==Solution structure of ascidian trypsin inhibitor==
<StructureSection load='1iw4' size='340' side='right'caption='[[1iw4]]' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[1iw4]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Halocynthia_roretzi Halocynthia roretzi]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1IW4 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1IW4 FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 20 models</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1iw4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1iw4 OCA], [https://pdbe.org/1iw4 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1iw4 RCSB], [https://www.ebi.ac.uk/pdbsum/1iw4 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1iw4 ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/ITRP_HALRO ITRP_HALRO] Potent inhibitor of trypsin.
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
The three-dimensional solution structure of ascidian trypsin inhibitor (ATI), a 55 amino acid residue protein with four disulfide bridges, was determined by means of two-dimensional nuclear magnetic resonance (2D NMR) spectroscopy. The resulting structure of ATI was characterized by an alpha-helical conformation in residues 35-42 and a three-stranded antiparallel beta-sheet in residues 22-26, 29-32, and 48-50. The presence of an alpha-helical conformation was predicted from the consensus sequences of the cystine-stabilized alpha-helical (CSH) motif, which is characterized by an alpha-helix structure in the Cys-X(1)-X(2)-X(3)-Cys portion (corresponding to residues 37-41), linking to the Cys-X-Cys portion (corresponding to residues 12-14) folded in an extended structure. The secondary structure and the overall folding of the main chain of ATI were very similar to those of the Kazal-type inhibitors, such as Japanese quail ovomucoid third domain (OMJPQ3) and leech-derived tryptase inhibitor form C (LDTI-C), although ATI does not show extensive sequence homology to these inhibitors except for a few amino acid residues and six of eight half-cystines. On the basis of these findings, we realign the amino acid sequences of representative Kazal-type inhibitors including ATI and discuss the unique structure of ATI with four disulfide bridges.


==Overview==
Solution structure of ascidian trypsin inhibitor determined by nuclear magnetic resonance spectroscopy.,Hemmi H, Yoshida T, Kumazaki T, Nemoto N, Hasegawa J, Nishioka F, Kyogoku Y, Yokosawa H, Kobayashi Y Biochemistry. 2002 Aug 27;41(34):10657-64. PMID:12186551<ref>PMID:12186551</ref>
The three-dimensional solution structure of ascidian trypsin inhibitor (ATI), a 55 amino acid residue protein with four disulfide bridges, was determined by means of two-dimensional nuclear magnetic resonance (2D NMR) spectroscopy. The resulting structure of ATI was characterized by an alpha-helical conformation in residues 35-42 and a three-stranded antiparallel beta-sheet in residues 22-26, 29-32, and 48-50. The presence of an alpha-helical conformation was predicted from the consensus sequences of the cystine-stabilized alpha-helical (CSH) motif, which is characterized by an alpha-helix structure in the Cys-X(1)-X(2)-X(3)-Cys portion (corresponding to residues 37-41), linking to the Cys-X-Cys portion (corresponding to residues 12-14) folded in an extended structure. The secondary structure and the overall folding of the main chain of ATI were very similar to those of the Kazal-type inhibitors, such as Japanese quail ovomucoid third domain (OMJPQ3) and leech-derived tryptase inhibitor form C (LDTI-C), although ATI does not show extensive sequence homology to these inhibitors except for a few amino acid residues and six of eight half-cystines. On the basis of these findings, we realign the amino acid sequences of representative Kazal-type inhibitors including ATI and discuss the unique structure of ATI with four disulfide bridges.


==About this Structure==
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
1IW4 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Halocynthia_roretzi Halocynthia roretzi]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1IW4 OCA].
</div>
<div class="pdbe-citations 1iw4" style="background-color:#fffaf0;"></div>


==Reference==
==See Also==
Solution structure of ascidian trypsin inhibitor determined by nuclear magnetic resonance spectroscopy., Hemmi H, Yoshida T, Kumazaki T, Nemoto N, Hasegawa J, Nishioka F, Kyogoku Y, Yokosawa H, Kobayashi Y, Biochemistry. 2002 Aug 27;41(34):10657-64. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/12186551 12186551]
*[[Trypsin inhibitor 3D structures|Trypsin inhibitor 3D structures]]
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Halocynthia roretzi]]
[[Category: Halocynthia roretzi]]
[[Category: Single protein]]
[[Category: Large Structures]]
[[Category: Hasegawa, J.]]
[[Category: Hasegawa J]]
[[Category: Hemmi, H.]]
[[Category: Hemmi H]]
[[Category: Kobayashi, Y.]]
[[Category: Kobayashi Y]]
[[Category: Kumazaki, T.]]
[[Category: Kumazaki T]]
[[Category: Kyogoku, Y.]]
[[Category: Kyogoku Y]]
[[Category: Nemoto, N.]]
[[Category: Nemoto N]]
[[Category: Nishioka, F.]]
[[Category: Nishioka F]]
[[Category: Yokosawa, H.]]
[[Category: Yokosawa H]]
[[Category: Yoshida, T.]]
[[Category: Yoshida T]]
[[Category: Ascidian]]
[[Category: Cystine-stabilized alpha-helical motif]]
[[Category: Disulfide bond]]
[[Category: Kazal-type inhibitor]]
[[Category: Nmr]]
[[Category: Solution structure]]
[[Category: Trypsin inhibitor]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 20:29:40 2008''
Retrieved from "https://proteopedia.org/1iw4"